Issue
Alert me when new journal issues are available via or via
Preface Fernand Labrie pages vii-ix Full Text | Full-Text PDF (61 KB)
Androgen formation and inactivation in the prostate-basis of combined androgen blockade
Androgen biosynthetic pathways in the human prostate Van Luu-The, Alain Bélanger, Fernand Labrie pages 207-221 Abstract | Full Text | Full-Text PDF (438 KB)
Expression of steroidogenic enzymes and sex-steroid receptors in human prostate Georges Pelletier pages 223-228 Abstract | Full Text | Full-Text PDF (873 KB)
Intra-prostatic androgen levels during various androgen-blockade regimens Tsutomu Nishiyama pages 229-241 Abstract | Full Text | Full-Text PDF (219 KB)
Intracrine androgen metabolism in prostate cancer progression: mechanisms of castration resistance and therapeutic implications Elahe A. Mostaghel, Peter S. Nelson pages 243-258 Abstract | Full Text | Full-Text PDF (225 KB)
Inactivation of androgens by UDP-glucuronosyltransferases in the human prostate Olivier Barbier, Alain Bélanger pages 259-270 Abstract | Full Text | Full-Text PDF (576 KB)
Morphological changes of combined androgen blockade and inhibition of precancerous lesions
Morphological changes induced by androgen blockade in normal prostate and prostatic carcinoma Bernard Têtu pages 271-283 Abstract | Full Text | Full-Text PDF (925 KB)
Androgen deprivation therapy for precancerous lesions of the prostate David Hull, David G. Bostwick pages 285-291 Abstract | Full Text | Full-Text PDF (206 KB)
Combined androgen blockade is curative in localized disease
Current status and prospects of androgen depletion therapy for prostate cancer Hideyuki Akaza pages 293-302 Abstract | Full Text | Full-Text PDF (579 KB)
Primary combined androgen blockade in localized disease and its mechanism Mikio Namiki, Yasuhide Kitagawa, Atsushi Mizokami, Eitetsu Koh pages 303-315 Abstract | Full Text | Full-Text PDF (547 KB)
The benefits of early androgen blockade Paul D. Maroni, E. David Crawford pages 317-329 Abstract | Full Text | Full-Text PDF (203 KB)
Combined androgen blockade in metastatic disease and resistance to treatment
Maximal androgen blockade for advanced prostate cancer Laurence Klotz pages 331-340 Abstract | Full Text | Full-Text PDF (131 KB)
Mechanisms of bone metastasis in prostate cancer: clinical implications Pavlos Msaouel, Nikos Pissimissis, Antonios Halapas, Michael Koutsilieris pages 341-355 Abstract | Full Text | Full-Text PDF (469 KB)
A role for the androgen-receptor in clinically localized and advanced prostate cancer James L. Mohler pages 357-372 Abstract | Full Text | Full-Text PDF (374 KB)
Mechanisms of prostate cancer progression to androgen independence Michael J. McPhaul pages 373-388 Abstract | Full Text | Full-Text PDF (457 KB)
Prevention of prostate cancer with 5∝-reductase inhibitors
5α-reductase inhibitors in benign prostatic hyperplasia and prostate cancer risk reduction Roger S. Rittmaster pages 389-402 Abstract | Full Text | Full-Text PDF (366 KB)
Keyword index page I1 Full-Text PDF (58 KB)
Copyright © 2010 Elsevier, Inc. All rights reserved | Privacy Policy | Terms & Conditions | Feedback | About Us | Help | Contact Us | The content on this site is intended for health professionals.
